Advantage Consumer Healthcare brings competitive edge with OTC focus
AUDIO Q&A: DSN caught up with Greg Bradley — president and CEO of Advantage Consumer Healthcare, a full turnkey solution center for over-the-counter medicines reaching the market — for an overview of the new marketing and sales solution company as it has recently brought to market OraSure Technologies’ OraQuick Advance, a take-home HIV test kit that the Food and Drug Administration recently approved for the self-care market, and Westport Pharmaceuticals’ Zephrex-D, a pseudoephedrine product with a unique point of differentiation.
Schnucks suffers cyberattack; issue contained
ST. LOUIS — Schnucks was the victim of a recent attack on its computer network that compromised its credit and debit card system, the supermarket chain said.
Saying that it had "found and contained" the issue behind the attack, Schnucks said that a computer code discovered by an outside computer forensic firm had been designed to capture magnetic stripe data on the back of cards.
"After an extensive review, we confirmed that Schnucks was the victim of a cyberattack," chairman and CEO Scott Schnuck said. "We have identified the issue and taken comprehensive measures to contain the incident. We are cooperating with law enforcement, the Missouri Attorney General’s Office and the credit card companies to determine the scope and magnitude of this crime and apprehend those individuals making fraudulent purchases."
The chain said it had made security enhancements to prevent the attacks from continuing, and that customers could continue using their credit and debit cards at Schnucks stores, and that the company would investigate how long the issue had existed and which stores were affected.
AmerisourceBergen sells contract pharmaceutical packaging business to Frazier Healthcare
PHILADELPHIA — Frazier Healthcare on Tuesday announced its acquisition of AndersonBrecon, the contract pharmaceutical packaging business and wholly owned subsidiary of AmerisourceBergen. Packaging Coordinators, a provider of pharmaceutical and biotechnology packaging services and Frazier Healthcare portfolio company, will combine with AndersonBrecon to offer services on a global scale.
"We are pleased to merge two stellar players within the pharmaceutical and biotech packaging business and believe that the combined company will deliver industry leading quality and service to our customers and a world-class environment for our employees," stated Nathan Every, Frazier Healthcare general partner and PCI board member.
The purchase price for the transaction is $308 million in cash, subject to customary adjustments for, among other things, the working capital of the business. In addition to Frazier, the investor group includes affiliates of Greenspring Associates, QIC Global Private Equity and Thomas McNerney & Partners, who were part of the transaction.
The purchase of AndersonBrecon is subject to customary closing conditions, including certain regulatory reviews, and is expected to close in the second quarter of 2013. RBC Capital Markets acted as exclusive financial advisor to PCI, Frazier Healthcare and co-sponsors.